Evidence map›Paper›PMID 19332776›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2009

Endocytic sequestration of the B cell antigen receptor and toll-like receptor 9 in anergic cells.

Shannon K O'Neill, Margaret L Veselits, Miao Zhang, Christine Labno, Yanxia Cao, Alison Finnegan, Melissa Uccellini, Maria-Luisa Alegre, John C Cambier, Marcus R Clark

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Cellular aspects of the pathogenesis of lupus nephritis.Current opinion in rheumatology · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Tolerant anti-insulin B cells are effective APCs.Journal of immunology (Baltimore, Md. : 1950) · 2013
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Shannon K O'NeillDepartment of Medicine, Section of Rheumatology, and The Knapp Center for Lupus Research, University of Chicago, Chicago, IL 60637, USA.
Margaret L Veselits
Miao Zhang
Christine Labno
Yanxia Cao
Alison Finnegan
Melissa Uccellini
Maria-Luisa Alegre
John C Cambier
Marcus R Clark
University of Chicago · USRush University Medical Center · USBoston University · USUniversity of Colorado Denver · USUniversity of Colorado Health · US

Funding

B CELL FUNCTION IN AUTOIMMUNE ARTHRITISR01AR047657 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI FINNEGAN, ALISON · 2002 to 2011
$3.0M
Relationships between B Cell Antigen Receptor Signaling and EndocytosisR21GM076601 · NIGMS · UNIVERSITY OF CHICAGO · PI CLARK, MARCUS R · 2006 to 2007
$227k
NIAMS NIH HHS R01 AR047657NIGMS NIH HHS R01 GM0677772NIGMS NIH HHS R21 GM076601
6 · The paper itself

Abstract

In autoimmune prone murine strains, sequential engagement of the B cell antigen receptor (BCR) on the cell surface and toll-like receptors (TLRs) in late endosomes is necessary and sufficient for secretion of autoantibodies. However, ubiquitous nucleoprotein self-antigens fail to elicit productive TLR activation, and break self-tolerance in anergic DNA-reactive B cells. The mechanisms limiting TLR activation in these cells are largely unknown. Here, we demonstrate that in anergic 3H9/Vkappa8 and Ars/A1 B cells the normal endocytic transit of both the ligated BCR and TLR9 into late endosomes is abrogated. The BCR and TLR9 arrest together just outside late endosomes, indicating that they enter this compartment along a single, regulated endocytic route. Access to late endosomes could be restored by reversing anergy through several methods, including conferring genetic susceptibility to autoimmunity, complementing proximal BCR signaling or by preventing BCR binding to self-antigen. Downstream of the BCR, JNK, which is activated in naive but not anergic B cells, regulated entry into late endosomes. Restoration of BCR and TLR9 endocytic trafficking rescued TLR9 activation by BCR-captured ligands. These results indicate that B cell anergy is reinforced by the exclusion of both TLRs and their BCR captured ligands from subcellular environments necessary for TLR activation.

Indexed as

AnimalsAntibodies, AntinuclearAntibodies, AntiphospholipidAntigens, LyB-LymphocytesClonal AnergyEndocytosisEnzyme ActivationJNK Mitogen-Activated Protein KinasesLigandsMiceMice, Inbred C57BLProtein TransportReceptors, Antigen, B-CellSpleenTime Factors3H9 protein, mouseAntibodies, AntinuclearAntibodies, AntiphospholipidAntigens, LyJNK Mitogen-Activated Protein KinasesLigandsReceptors, Antigen, B-CellToll-Like Receptor 9

Identifiers

PMID19332776
PMCPMC2662959
OpenAlexW2063166183

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.